RT3

Triple-agonist incretin candidate for advanced metabolic work.

Triple-agonist incretin candidate for advanced metabolic work
Purity ≥ 99.8% (HPLC)
Lot-specific COA ships with every order

Secure checkout · Free shipping over $60 · Damage protected

Order within

3rd-party tested

Free ship over $60

Damage protected

The why

RT3 is an investigational multi-receptor incretin analog used in laboratory models of energy expenditure, glucose regulation and appetite signaling.

Key ingredients

RT3 10 mg / 20 mg / 30 mg / 50 mg
Sterile lyophilized powder

Certificate of Analysis

Every lot, tested and documented.

Independent third-party analysis on every RT3 lot by Vanguard Laboratory (A2LA accredited). Purity, quantity, identity, heavy metals, endotoxins and bioburden. The results below are pulled straight from the signed report.

Verified by Vanguard HPLC-UV/VIS ICP-MS USA-shipped

Vanguard Laboratory · Level 3 verified

Veyron-RT3

Open signed COA

Lot number

RT3.10.A

Laboratory ID

V260617-22009

Date reported

6/25/2026

Report number

V260617-22 009

Chromatographic purity

>99.80%

Quantity per vial

10.95 mg

Endotoxins (LAL)

Pass - <5.00 EU/mg

Bioburden (USP 61)

Pass - No Growth Detected

Heavy metals (ICP-MS)

Not detected

Signed by

Dustin Newman, Laboratory Director

Values above are transcribed from the Vanguard Laboratory report for lot RT3.10.A. Heavy metals reported as ND (not detected) for arsenic, cadmium, lead and mercury. Open the signed PDF for chromatograms and the full analyte table.

What we test

Purity + identity
>99.80%
HPLC-UV/VIS chromatographic purity against a reference standard.
Quantity
10.95 mg
Confirms the vial holds at least what the label says.
Heavy metals
Not detected
ICP-MS screen for arsenic, cadmium, lead and mercury.
Endotoxins + bioburden
Pass - <5.00 EU/mg
LAL endotoxin assay and USP 61 microbial count screening.